The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.
Consumer groups said they were shocked by the amount that AES Indiana is seeking, especially coming after the utility got approval for seven straight years of rate increases to pay for upgrades to its local energy grid.
In the health care world, Thermo Fisher Scientific operates mostly behind the scenes, supplying labs and hospitals with scientific instruments, chemical ingredients and software services.
The New Jersey-based company has announced two large rounds of layoffs at its Bloomington plant within six months—400 workers last December and 150 this month.
At least six separate lawsuits have been filed this month in U.S. District Court in Indianapolis against Apria Healthcare LLC. Most of the suits are seeking class-action status on behalf of the 1.8 million people whose information was hacked by an unauthorized third party.
Dice has a proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology.
A federal judge is allowing three central Indiana women who discovered they were among the nearly 100 “secret children” of a former fertility doctor to move ahead with their lawsuit.
An Indianapolis woman is suing Community Health Network after the hospital system mailed her test results to the wrong person and that person posted the information on Facebook.
According to a federal complaint, the woman submitted $556,797 in false claims to Medicaid for portable medical devices known as oximeters and wired the money to her personal bank account.
The hospital system confirmed Monday that it priced the bonds at $726 million on June 6 and expects to close on the offering July 6. The bonds will help finance IU Health’s new downtown hospital.
The Indianapolis-based pharmaceutical giant is spending hundreds of millions of dollars to win over patients with an extensive advertising campaign.
The move marks the end of Fort Wayne-based Lutheran Hospital’s transplant program. It had stopped performing kidney transplants several years ago.
Under the agreement, Lilly has agreed to continue its cap on out-of-pocket costs for its users at $35 a month for four years.
But nearly half of Indiana’s corn is turned into ethanol as a fuel blend for cars, and nearly one-quarter of the soybean crop is turned into biodiesel for heavy-duty trucks.
The Indianapolis-based radiopharmaceutical company said it plans to help open a facility in Belgium to make therapeutic agents for cancer patients.
Officials of the two-year-old firm that provides professional services in the health care and life science industries expect the offering to raise up to $8 million.
A judge ruled that Indianapolis-based Lilly was liable for higher payments due to its behavior in making false statements to the Centers for Medicare and Medicaid Services about the prices it charged distributors for its drugs.
Senate Enrolled Act 8 is part of a sweeping effort this year by the Indiana General Assembly to bring down the cost of health care across the state, where prices are among the highest in the country.
Eli Lilly and Co. shares have soared 57% over the past 52 weeks, buoyed in part by sales of its diabetes drug Mounjaro, which the company is also preparing to seek approval to market for obesity.
The Bloomington-based maker of medical devices said the move is part of a new plan to strongly focus on product innovation.
